Imatinib Drug Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2019 - 2024

Report Code: HCR 78270 Report Format: PDF + Excel (Delivery in 48 Hrs)
1. Imatinib Drug Market - Overview
        1.1 Definitions and Scope
2. Imatinib Drug Market - Executive summary
        2.1 Market Revenue, Market Size and Key Trends by Company
        2.2 Key Trends by type of Application
        2.3 Key Trends segmented by Geography
3. Imatinib Drug Market
        3.1 Comparative analysis
            3.1.1 Product Benchmarking - Top 10 companies
            3.1.2 Top 5 Financials Analysis
            3.1.3 Market Value split by Top 10 companies
            3.1.4 Patent Analysis - Top 10 companies
            3.1.5 Pricing Analysis
4. Imatinib Drug Market - Startup companies Scenario Premium
        4.1 Top 10 startup company Analysis by
            4.1.1 Investment
            4.1.2 Revenue
            4.1.3 Market Shares
            4.1.4 Market Size and Application Analysis
            4.1.5 Venture Capital and Funding Scenario
5. Imatinib Drug Market - Industry Market Entry Scenario Premium
        5.1 Regulatory Framework Overview
        5.2 New Business and Ease of Doing business index
        5.3 Case studies of successful ventures
        5.4 Customer Analysis - Top 10 companies
6. Imatinib Drug Market Forces
        6.1 Drivers
        6.2 Constraints
        6.3 Challenges
        6.4 Porters five force model
            6.4.1 Bargaining power of suppliers
            6.4.2 Bargaining powers of customers
            6.4.3 Threat of new entrants
            6.4.4 Rivalry among existing players
            6.4.5 Threat of substitutes
7. Imatinib Drug Market -Strategic analysis
        7.1 Value chain analysis
        7.2 Opportunities analysis
        7.3 Product life cycle
        7.4 Suppliers and distributors Market Share
8. Imatinib Drug Market - By Product (Market Size -$Million / $Billion)
        8.1 Market Size and Market Share Analysis
        8.2 Application Revenue and Trend Research
        8.3 Product Segment Analysis
9. Imatinib Drug Market - By Drug Formulation (Market Size -$Million / $Billion)
9.1 Tablet
9.2 Capsule
10. Imatinib Drug - By Application (Market Size -$Million / $Billion)
        10.1 Segment type Size and Market Share Analysis
        10.2 Application Revenue and Trends by type of Application
        10.3 Application Segment Analysis by Type
            10.3.1 Aggressive Systemic Mastocytosis
            10.3.2 Chronic Eosinophilic Leukemia
            10.3.3 Dermatofibrosarcoma Protuberans
            10.3.4 Gastrointestinal Stromal Tumor
            10.3.5 Hyper-Eosinophilic Syndrome
            10.3.6 Myelodysplastic Syndrome
            10.3.7 Myeloproliferative Disease
            10.3.8 Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
            10.3.9 Philadelphia Chromosome Positive Chronic Myeloid Leukemia
11. Imatinib Drug- By Geography (Market Size -$Million / $Billion)
        11.1 Imatinib Drug Market - North America Segment Research
        11.2 North America Market Research (Million / $Billion)
            11.2.1 Segment type Size and Market Size Analysis
            11.2.2 Revenue and Trends
            11.2.3 Application Revenue and Trends by type of Application
            11.2.4 Company Revenue and Product Analysis
            11.2.5 North America Product type and Application Market Size
                  11.2.5.1 U.S
                  11.2.5.2 Canada
                  11.2.5.3 Mexico
                  11.2.5.4 Rest of North America
        11.3 Imatinib Drug- South America Segment Research
        11.4 South America Market Research (Market Size -$Million / $Billion)
            11.4.1 Segment type Size and Market Size Analysis
            11.4.2 Revenue and Trends
            11.4.3 Application Revenue and Trends by type of Application
            11.4.4 Company Revenue and Product Analysis
            11.4.5 South America Product type and Application Market Size
                  11.4.5.1 Brazil
                  11.4.5.2 Venezuela
                  11.4.5.3 Argentina
                  11.4.5.4 Ecuador
                  11.4.5.5 Peru
                  11.4.5.6 Colombia
                  11.4.5.7 Costa Rica
                  11.4.5.8 Rest of South America
        11.5 Imatinib Drug- Europe Segment Research
        11.6 Europe Market Research (Market Size -$Million / $Billion)
            11.6.1 Segment type Size and Market Size Analysis
            11.6.2 Revenue and Trends
            11.6.3 Application Revenue and Trends by type of Application
            11.6.4 Company Revenue and Product Analysis
            11.6.5 Europe Segment Product type and Application Market Size
                  11.6.5.1 U.K
                  11.6.5.2 Germany
                  11.6.5.3 Italy
                  11.6.5.4 France
                  11.6.5.5 Netherlands
                  11.6.5.6 Belgium
                  11.6.5.7 Denmark
                  11.6.5.8 Spain
                  11.6.5.9 Rest of Europe
        11.7 Imatinib Drug - APAC Segment Research
        11.8 APAC Market Research (Market Size -$Million / $Billion)
            11.8.1 Segment type Size and Market Size Analysis
            11.8.2 Revenue and Trends
            11.8.3 Application Revenue and Trends by type of Application
            11.8.4 Company Revenue and Product Analysis
            11.8.5 APAC Segment - Product type and Application Market Size
                  11.8.5.1 China
                  11.8.5.2 Australia
                  11.8.5.3 Japan
                  11.8.5.4 South Korea
                  11.8.5.5 India
                  11.8.5.6 Taiwan
                  11.8.5.7 Malaysia
                  11.8.5.8 Hong kong
                  11.8.5.9 Rest of APAC
        11.9 Imatinib Drug - Middle East Segment and Africa Segment Research
        11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
            11.10.1 Segment type Size and Market Size Analysis
            11.10.2 Revenue and Trend Analysis
            11.10.3 Application Revenue and Trends by type of Application
            11.10.4 Company Revenue and Product Analysis
            11.10.5 Middle East Segment Product type and Application Market Size
                  11.10.5.1 Israel
                  11.10.5.2 Saudi Arabia
                  11.10.5.3 UAE
            11.10.6 Africa Segment Analysis
                  11.10.6.1 South Africa
                  11.10.6.2 Rest of Middle East & Africa
12. Imatinib Drug Market - Entropy
        12.1 New product launches
        12.2 M&A s, collaborations, JVs and partnerships
13. Imatinib Drug Market - Industry / Segment Competition landscape Premium
        13.1 Market Share Analysis
            13.1.1 Market Share by Country- Top companies
            13.1.2 Market Share by Region- Top 10 companies
            13.1.3 Market Share by type of Application - Top 10 companies
            13.1.4 Market Share by type of Product / Product category- Top 10 companies
            13.1.5 Market Share at global level - Top 10 companies
            13.1.6 Best Practises for companies
14. Imatinib Drug Market - Key Company List by Country Premium
15. Imatinib Drug Market Company Analysis
        15.1 Market Share, Company Revenue, Products, M&A, Developments
        15.2 Actavis Generic
        15.3 Apotex Inc
        15.4 Cipla Inc
        15.5 Dr. Reddy'S Laboratory
        15.6 Glenmark Pharmaceutical Ltd
        15.7 Mylan Pharms Inc
        15.8 Novartis
        15.9 Sanofi S A
        15.10 Sun Pharmaceutical
        15.11 Teva Pharmaceutical Industry Ltd
        15.12 Company 12
        15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. Imatinib Drug Market - Appendix
        16.1 Abbreviations
        16.2 Sources
17. Imatinib Drug Market - Methodology
        17.1 Research Methodology
            17.1.1 Company Expert Interviews
            17.1.2 Industry Databases
            17.1.3 Associations
            17.1.4 Company News
            17.1.5 Company Annual Reports
            17.1.6 Application Trends
            17.1.7 New Products and Product database
            17.1.8 Company Transcripts
            17.1.9 R&D Trends
            17.1.10 Key Opinion Leaders Interviews
            17.1.11 Supply and Demand Trends

LIST OF TABLES

1.Global Imatinib Drug Market, By Drug Formulation Market 2019-2024 ($M)
1.1 Tablet Market 2019-2024 ($M) - Global Industry Research
1.2 Capsule Market 2019-2024 ($M) - Global Industry Research
2.Global Imatinib Drug Market, By Drug Formulation Market 2019-2024 (Volume/Units)
2.1 Tablet Market 2019-2024 (Volume/Units) - Global Industry Research
2.2 Capsule Market 2019-2024 (Volume/Units) - Global Industry Research
3.North America Imatinib Drug Market, By Drug Formulation Market 2019-2024 ($M)
3.1 Tablet Market 2019-2024 ($M) - Regional Industry Research
3.2 Capsule Market 2019-2024 ($M) - Regional Industry Research
4.South America Imatinib Drug Market, By Drug Formulation Market 2019-2024 ($M)
4.1 Tablet Market 2019-2024 ($M) - Regional Industry Research
4.2 Capsule Market 2019-2024 ($M) - Regional Industry Research
5.Europe Imatinib Drug Market, By Drug Formulation Market 2019-2024 ($M)
5.1 Tablet Market 2019-2024 ($M) - Regional Industry Research
5.2 Capsule Market 2019-2024 ($M) - Regional Industry Research
6.APAC Imatinib Drug Market, By Drug Formulation Market 2019-2024 ($M)
6.1 Tablet Market 2019-2024 ($M) - Regional Industry Research
6.2 Capsule Market 2019-2024 ($M) - Regional Industry Research
7.MENA Imatinib Drug Market, By Drug Formulation Market 2019-2024 ($M)
7.1 Tablet Market 2019-2024 ($M) - Regional Industry Research
7.2 Capsule Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Imatinib Drug Market Revenue, 2019-2024 ($M)
2.Canada Imatinib Drug Market Revenue, 2019-2024 ($M)
3.Mexico Imatinib Drug Market Revenue, 2019-2024 ($M)
4.Brazil Imatinib Drug Market Revenue, 2019-2024 ($M)
5.Argentina Imatinib Drug Market Revenue, 2019-2024 ($M)
6.Peru Imatinib Drug Market Revenue, 2019-2024 ($M)
7.Colombia Imatinib Drug Market Revenue, 2019-2024 ($M)
8.Chile Imatinib Drug Market Revenue, 2019-2024 ($M)
9.Rest of South America Imatinib Drug Market Revenue, 2019-2024 ($M)
10.UK Imatinib Drug Market Revenue, 2019-2024 ($M)
11.Germany Imatinib Drug Market Revenue, 2019-2024 ($M)
12.France Imatinib Drug Market Revenue, 2019-2024 ($M)
13.Italy Imatinib Drug Market Revenue, 2019-2024 ($M)
14.Spain Imatinib Drug Market Revenue, 2019-2024 ($M)
15.Rest of Europe Imatinib Drug Market Revenue, 2019-2024 ($M)
16.China Imatinib Drug Market Revenue, 2019-2024 ($M)
17.India Imatinib Drug Market Revenue, 2019-2024 ($M)
18.Japan Imatinib Drug Market Revenue, 2019-2024 ($M)
19.South Korea Imatinib Drug Market Revenue, 2019-2024 ($M)
20.South Africa Imatinib Drug Market Revenue, 2019-2024 ($M)
21.North America Imatinib Drug By Application
22.South America Imatinib Drug By Application
23.Europe Imatinib Drug By Application
24.APAC Imatinib Drug By Application
25.MENA Imatinib Drug By Application
26.Novartis, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Glenmark Pharmaceutical Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Sun Pharmaceutical, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Actavis Generic, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Dr. Reddy'S Laboratory, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Teva Pharmaceutical Industry Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Sanofi S A, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Cipla Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Apotex Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Mylan Pharms Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)